Berson & Corrado Investment Advisors, LLC
Q2 2014 13F-HR Holdings
Net value change ($000)
+24,168
(11.8%)
New positions
8
Sold out positions
6
Turnover %
16.3%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2014
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| AAPL | 9,085 | NEW |
| FEZ | 6,023 | NEW |
| C | 2,899 | NEW |
| Acadia Pharmaceuticals | 2,803 | NEW |
| CLMT | 2,384 | 22.8% |
| GOLDCORP INC NEW | 2,059 | 27.6% |
| DVN | 1,875 | 20.8% |
| OSG | 1,403 | 22.2% |
| TNK | 1,387 | 24.0% |
| TRONOX LTD | 1,374 | 12.5% |
Top Reduces (Value $000, Stocks/ETFs)
| APPLE INC | -7,721 | -100.0% |
| C | -2,929 | -100.0% |
| ACAD | -1,097 | -100.0% |
| GLDI | -993 | -100.0% |
| Promotora De Info Adr Bf | -885 | -25.5% |
| TDAY | -415 | -6.4% |
| Arrowhead Pharma Inc | -400 | -100.0% |
| BOND | -362 | -100.0% |
| Hi-Crush Inc. | -358 | -28.0% |
| ENDOCYTE INC | -302 | -81.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|